Asymmetric dimethylarginine and all-cause mortality: a systematic review and meta-analysis

Asymmetrical dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide synthase (NOS), impairs the beneficial effect of NO. The predictive value of ADMA for all-cause mortality remains controversial, though it is important in the development of cardiovascular disease (CVD) and progression to...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Shaoli, Zhu, Qianqian, Li, Xiang, Chen, Chaojin, Liu, Jiping, Ye, Yuping, Ruan, Ying, Hei, Ziqing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353714/
https://www.ncbi.nlm.nih.gov/pubmed/28294182
http://dx.doi.org/10.1038/srep44692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5353714/
https://www.ncbi.nlm.nih.gov/pubmed/28294182
http://dx.doi.org/10.1038/srep44692

Ejemplares similares